OPKO Health (OPK) Tops Q4 EPS by 3c, provides guidance
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.43 --0%
EPS Growth %: +63.2%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +63.2%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $148.5 million versus the consensus estimate of $139.76 million.
GUIDANCE:
OPKO Health sees Q1 2026 revenue of $125-140 million, versus the consensus of $130.8 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- DOE To Make $17.5B In Loans Available To Finance Nuclear - WSJ
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
